Burlington Got Crushed. Its Earnings Didn't Get the Memo.

# Burlington Got Crushed. Its Earnings Didn't Get the Memo.

Somebody sold Burlington Stores like the company forgot how to run a discount retailer. Down 21.4% in a week, nearly 30% on the month, RSI cratered to 15.81 — a reading so deep into oversold territory it's practically begging for a bounce. And yet, buried under all that red, Burlington just posted its 15th consecutive quarter of double-digit EPS growth. Fifteen. In a row. Q2 net income landed at $184 million, adjusted EPS jumped 38%, sales rose 11%. That is not the profile of a company falling apart. That's the profile of a stock that got thrown out with the market's bathwater.

So which is it — a broken business or a broken chart?

The case for the bounce

Technically, this is about as textbook as oversold gets. Price is sitting at $259.76, well below the prior consolidation shelf and miles under the old base target of $314. Support has repeatedly shown up in the $240–$260 zone, and when a stock this beaten-down is still compounding EPS at a double-digit clip, the market usually figures that out eventually. Management isn't sitting on its hands either — the $55 million plan to funnel tariff savings back into store expansion and margin work is a real, tangible signal that leadership sees runway, not retreat. Gross margins are holding near 44%. This isn't a melting ice cube; it's a discount retailer that's actually executing while the tape treats it like a distressed asset.

The case for staying cautious

Here's where I have to be the annoying voice in the room: oversold doesn't mean cheap, and a hot EPS streak doesn't mean a healthy balance sheet. Burlington is carrying roughly $5.9 billion in total debt against $1.8 billion in equity — a debt-to-equity ratio near 3x. The quick ratio of 1.17 says working capital is tighter than you'd like for a company this leveraged. None of that is disqualifying on its own, but it means every dollar of that 38% EPS growth is doing double duty: funding growth and servicing a debt load that doesn't care how oversold your RSI is.

The Street reflects that tension. Goldman Sachs kept its Buy rating but trimmed the target to $382. Deutsche Bank stayed at Hold and cut theirs to $323. That's not a consensus screaming "back up the truck" — it's analysts hedging between a genuinely strong operating story and a genuinely leveraged balance sheet in a market that's currently allergic to both retail cyclicality and risk.

My read

This is a trade, not a conviction thesis — at least not yet. The setup screams tactical bounce: extreme RSI, real support levels, a fundamental story that hasn't cracked, and a sell-off that looks more like macro risk-off contagion than a Burlington-specific breakdown. If you're inclined to fade panic, $240–$260 is where you'd want to be watching, not chasing the stock at its lows out of fear of missing the reversal.

But don't confuse a bounce with a re-rating. Until Burlington shows it can keep growing EPS at this pace while bringing that debt load down to something less hair-raising, this stays a "trade the range, don't marry the story" situation. The 15-quarter streak is genuinely impressive — I'm not dismissing it — but streaks end, and leverage doesn't forgive slower quarters the way equity investors do.

What to watch

Q3 earnings, likely landing in October or November, are the next real catalyst — either validation that the reinvestment plan is paying off, or the first crack in a streak that's starting to look almost too good to be sustainable. Trade policy clarity on tariffs matters too, since some of this margin strength is sitting on savings that could evaporate with the next policy swing.

Bottom line: Burlington's chart says "buy the fear." Burlington's balance sheet says "know what you own." Both can be true at the same time — that's exactly why this is a bounce play, not a bet on destiny.